Search Results - david+eisenberg

4 Results Sort By:
Nitrogen-doped graphene-rich carbon materials for technological applications
This invention describes a low-temperature pyrolysis method to produce graphene-rich carbon materials using hexagonal metal oxides as templates. The process prevents graphene stacking into graphite and allows nitrogen doping, enhancing properties for applications like electrodes and catalysts. Background Graphene, a single layer of carbon atoms arranged...
Published: 10/11/2024   |   Inventor(s): Adam Heller, Keith Friedman, Sheryl Coffman, David Eisenberg, Joo-Woon Lee
Keywords(s):  
Category(s): Life sciences > Medical technology > Medical devices
2019-701 PEPTIDE-BASED INHIBITORS THAT BLOCK AGGREGATION, SEEDING AND CROSS-SEEDING OF AMYLOID BETA AND TAU
UCLA researchers in the Department of Chemistry and Biochemistry have developed novel therapeutics for Alzhiemer’s Disease and other tauoapathies. BACKGROUND:Alzhiemer’s Disease (AD) is a severe neurodegenerative disease characterized by deterioration of the brain cells and loss of multiple cognitive functions. Although AD is the most...
Published: 5/20/2025   |   Inventor(s): David Eisenberg, Paul Seidler
Keywords(s): Cns, Therapeutics & Vaccines
Category(s): Therapeutics > CNS and Neurology
2004-087 Antimicrobial Peptide for the Treatment of Skin Diseases
Antimicrobial Peptide for the Treatment of Skin DiseasesSUMMARYGranulysin peptides are small antimicrobial agents with potent activity against bacteria and inflammation. A pharmaceutical composition comprising granulysin peptides as an active agent is administered therapeutically to a patient suffering from a microbial infection.
Published: 2/14/2025   |   Inventor(s): David Eisenberg, Robert Modlin, Jenny Kim, Daniel Anderson, Richard Gallo
Keywords(s): Dermatology, Therapeutics & Vaccines
Category(s): Therapeutics, Therapeutics > Dermatology
2016-694 INHIBITION OF THE AGGREGATION OF TRANSTHYRETIN BY SPECIFIC BINDING OF PEPTIDES TO AGGREGATION-DRIVING SEGMENTS
Inhibition of the Aggregation of Transthyretin by Specific Binding of Peptides to Aggregation-Driving SegmentsSUMMARYUCLA researchers from the Department of Chemistry and Biochemistry have developed a novel process to inhibit amyloid aggregation of Transthyretin, which is associated with three debilitating disorders including senile systemic amyloidosis...
Published: 2/14/2025   |   Inventor(s): David Eisenberg, Lorena Saelices Gomez
Keywords(s): Cardiovascular, Cns, Genetic Disease, Hematology, Therapeutics & Vaccines
Category(s): Therapeutics, Therapeutics > Cardiovascular, Therapeutics > Hematology, Therapeutics > CNS and Neurology